Pharmacoeconomic evaluation of treating acute venous thromboembolism with rivaroxaban in the inpatient setting

Autor: MV Avksentyeva, OV Shatalova

Publikováno v: Медицинский совет, Vol 0, Iss 8, Pp 18-23 (2014)

Cost reduction associated with the use of rivaroxaban compared with the enoxaparin + warfarin combination for for deep vein thrombosis and pulmonary thromboembolism when treated in the inpatient setting. The choice of the cost reduction method is con

Externí odkaz: https://doaj.org/article/a7cf9369d2a1498985e9a4ea259d4225

[Typical management practice in outpatients with type 2 diabetes mellitus in cities, towns, and villages].

Autor: Sapozhnikova IE; Kirov State Medical Academy, Ministry of Health of Russia, Kirov, Russia., Tarlovskaya EI; Nizhny Novgorod State Medical Academy, Ministry of Health of Russia, Nizhny Novgorod, Russia., Avksentyeva MV; Institute of Applied Economic Researches, Russian Presidential Academy of National Economy and Public Administration, Moscow, Russia; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2016; Vol. 88 (1), pp. 75-81.